Anti-Cancer Drugs Journal Issues Research Articles in July 2023 Edition
May 15, 2023
May 15, 2023
LONDON, England, May 15 -- Anti-Cancer Drugs, a journal that says it reports clinical and experimental results related to anti-cancer drugs and welcomes contributions on anti-cancer drug design, drug delivery, pharmacology, hormonal and biological modalities and chemotherapy evaluation, published research articles on the following topics in its July 2023 edition:
Pre-Clinical Reports:
* Panaxadiol targeting IL2 inducible T cell kinase promotes T cell immunity in radiot . . .
Pre-Clinical Reports:
* Panaxadiol targeting IL2 inducible T cell kinase promotes T cell immunity in radiot . . .